← back to search

Yi‐Ling Chen

Hong Kong University of Science and Technology · HK
Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Mesenchymal stem cell research, Lung Cancer Diagnosis and Treatment, Angiogenesis and VEGF in Cancer, and Pleural and Pulmonary Diseases.
h-index
48
citations
8,572
works
394
NIH funding
primary concept
email

Recent publications

LC–MS and MALDI–MSI-based metabolomic approaches provide insights into the spatial–temporal metabolite profiles of Tartary buckwheat achene development
Food Chemistry 2024cited by 15position: middledoi
Experimental study and numerical simulation verification of the macro- and micromechanical properties of the sandstone–concrete interface under freeze–thaw cycles
Construction and Building Materials 2024cited by 15position: middledoi
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis
Clinical Gastroenterology and Hepatology 2024cited by 10position: middledoi
Exploring the mechanism of Cinnamomi Cortex against morphine addiction using network pharmacology and molecular docking analyses.
PubMed 2024cited by 0position: middle
Construction of high-content α-iron on zero-valent iron @ biochar composite for the ultra-efficient removal of oxytetracycline hydrochloride: A key step of ammonium bicarbonate pretreatment
Separation and Purification Technology 2023cited by 15position: lastdoi
Effects of dietary adenosine and adenosine 5′-monophosphate supplementation on carcass characteristics, meat quality, and lipid metabolism in adipose tissues of finishing pigs
Meat Science 2023cited by 10position: middledoi
CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis
Figshare 2023cited by 0position: middledoi
Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration
Signal Transduction and Targeted Therapy 2022cited by 83position: middledoi
Genome‐Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment
Advanced Science 2022cited by 33position: middledoi
Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis
American Journal of Respiratory Cell and Molecular Biology 2022cited by 5position: middledoi
PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1/Akt pathway
International Journal of Medical Sciences 2020cited by 35position: middledoi
CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes Infection
PLoS ONE 2016cited by 21position: middledoi
A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines
PLoS ONE 2013cited by 117position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaomin Song · Jiangxi Academy of Agricultural Sciences2 papers (2022–2022)Bolun Li · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2022–2022) · 2 papers (2022–2022)Meiyue Song · Harbin Medical University2 papers (2022–2022) · 2 papers (2022–2022)Zhujie Cao · Shanxi Medical University2 papers (2022–2022)Huiyuan Hu · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2022–2022)Zhe Zhang · Fudan University2 papers (2022–2022)Wei Yang · Sun Yat-sen University Cancer Center1 papers (2024–2024) · 1 papers (2013–2013) · 1 papers (2020–2020) · 1 papers (2023–2023)Li Feng · Central South University1 papers (2023–2023) · 1 papers (2024–2024)Linghong Chen · Ningbo University1 papers (2024–2024)Lin Hou · Shandong University of Traditional Chinese Medicine1 papers (2022–2022)Siqi Wu · Fudan University1 papers (2023–2023)Tao He · Shandong University1 papers (2023–2023)Vincent Wai‐Hin Yuen · University of Hong Kong1 papers (2022–2022) · 1 papers (2022–2022)